Search

Your search keyword '"Baden, Lindsey R."' showing total 342 results

Search Constraints

Start Over You searched for: Author "Baden, Lindsey R." Remove constraint Author: "Baden, Lindsey R." Search Limiters Full Text Remove constraint Search Limiters: Full Text Language english Remove constraint Language: english
342 results on '"Baden, Lindsey R."'

Search Results

1. Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

2. Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases

4. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

5. Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study

6. Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

7. Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

8. Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results

10. Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice

11. Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice

12. The BNT162b2 mRNA vaccine demonstrates reduced age-associated TH1 support in vitro and in vivo

14. Risk of COVID-19 after natural infection or vaccination

15. Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial

16. Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donors

17. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients

18. Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies

19. Diagnostic TR-FRET assays for detection of antibodies in patient samples

20. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study

24. Disseminated Mycobacterium avium Complex Infection Following CD3/CD20 Bispecific Antibody Therapy in a Patient With Follicular Lymphoma.

26. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases

28. Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults

30. Humoral signatures of protective and pathological SARS-CoV-2 infection in children

31. SARS-CoV-2 Polymerase Chain Reaction Cycle Threshold Trends in Patients Who Are Immunocompromised and Implications for Isolation Precautions.

32. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

33. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

35. Plateletpheresis-associated lymphopenia in frequent platelet donors

37. Preexisting memory CD[4.sup.+] T cells contribute to the primary response in an HIV-1 vaccine trial

38. Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge

39. Immune Control in Repeated Babesia microti Infection in a Patient With B-Cell Deficiency.

40. Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

41. Corrigendum to “Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study” [eBioMedicine 83 (2022) 104208]

44. SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients.

45. Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.

46. SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

49. Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

Catalog

Books, media, physical & digital resources